Cargando…
A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging
Chagas disease, caused by the intracellular protozoan Trypanosoma cruzi, affects 8–10 million people worldwide and represents a major public health challenge. There is no effective treatment or vaccine to control the disease that is characterized by a mild acute phase followed by a chronic life-long...
Autores principales: | Silberstein, Erica, Serna, Carylinda, Fragoso, Stenio Perdigão, Nagarkatti, Rana, Debrabant, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908157/ https://www.ncbi.nlm.nih.gov/pubmed/29672535 http://dx.doi.org/10.1371/journal.pone.0195879 |
Ejemplares similares
-
Aptamer Based, Non-PCR, Non-Serological Detection of Chagas Disease Biomarkers in Trypanosoma cruzi Infected Mice
por: Nagarkatti, Rana, et al.
Publicado: (2014) -
Clathrin expression in Trypanosoma cruzi
por: Kalb, Ligia Cristina, et al.
Publicado: (2014) -
Development of an Aptamer-Based Concentration Method for the Detection of Trypanosoma cruzi in Blood
por: Nagarkatti, Rana, et al.
Publicado: (2012) -
Human Placental Trophoblasts Are Resistant to Trypanosoma cruzi Infection in a 3D-Culture Model of the Maternal-Fetal Interface
por: Silberstein, Erica, et al.
Publicado: (2021) -
The transcriptome landscape of 3D-cultured placental trophoblasts reveals activation of TLR2 and TLR3/7 in response to low Trypanosoma cruzi parasite exposure
por: Silberstein, Erica, et al.
Publicado: (2023)